57 related articles for article (PubMed ID: 8587603)
1. Vasoactive effects of fibrinogen on saphenous vein.
Hicks RC; Golledge J; Mir-Hasseine R; Powell JT
Nature; 1996 Feb; 379(6568):818-20. PubMed ID: 8587603
[TBL] [Abstract][Full Text] [Related]
2. Circumferential deformation and shear stress induce differential responses in saphenous vein endothelium exposed to arterial flow.
Golledge J; Turner RJ; Harley SL; Springall DR; Powell JT
J Clin Invest; 1997 Jun; 99(11):2719-26. PubMed ID: 9169502
[TBL] [Abstract][Full Text] [Related]
3. Arterial flow induces changes in saphenous vein endothelium proteins transduced by cation channels.
Golledge J; Gosling M; Turner RJ; Standfield NJ; Powell JT
Eur J Vasc Endovasc Surg; 2000 May; 19(5):545-50. PubMed ID: 10828238
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells.
Harley SL; Powell JT
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):739-44. PubMed ID: 10417339
[TBL] [Abstract][Full Text] [Related]
5. Fibrin monomer and fibrinopeptide B act additively to increase DNA synthesis in smooth muscle cells cultured from human saphenous vein.
Sturge J; Carey N; Davies AH; Powell JT
J Vasc Surg; 2001 Apr; 33(4):847-53. PubMed ID: 11296341
[TBL] [Abstract][Full Text] [Related]
6. Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit.
Amerini S; Filippi S; Parenti A; Ledda F; Ziche M
Br J Pharmacol; 1997 Dec; 122(8):1739-45. PubMed ID: 9422822
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of atherosclerosis and saphenous vein endothelial function.
Sessa C; Morasch MD; Friedland M; Kline RA
Int Angiol; 2001 Jun; 20(2):152-63. PubMed ID: 11533524
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil adherence to activated saphenous vein and mammary endothelium after graft preparation.
Schlitt A; Pruefer D; Buerke U; Russ M; Dahm M; Oelert H; Werdan K; Buerke M
Ann Thorac Surg; 2006 Apr; 81(4):1262-8. PubMed ID: 16564255
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein.
Masood I; Porter KE; London NJ
Br J Surg; 1997 Apr; 84(4):499-503. PubMed ID: 9112901
[TBL] [Abstract][Full Text] [Related]
10. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
[TBL] [Abstract][Full Text] [Related]
13. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery.
Dashwood MR
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():78-87. PubMed ID: 19335750
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
Fabi F; Argiolas L; Ruvolo G; del Basso P
Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
[TBL] [Abstract][Full Text] [Related]
16. Saphenous vein grafts display poor endothelium-dependent and endothelium-independent dilation--implications for the pathogenesis of vein graft atherosclerosis.
Kilian JG; Thanyasiri P; Celermajer DS; Adams MR
Heart Lung Circ; 2008 Apr; 17(2):96-9. PubMed ID: 17768090
[TBL] [Abstract][Full Text] [Related]
17. [Structural and functional aspects of the human saphenous vein used as aorto-coronary graft in myocardial revascularization].
Milesi V; Rebolledo A; Gómez Alvis A; Sanz N; Tommasi J; Drago A; Raingo J; Rinaldi GJ; Grassi de Gende AO
Medicina (B Aires); 2001; 61(4):481-90. PubMed ID: 11563178
[TBL] [Abstract][Full Text] [Related]
18. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue.
Gonçalves RL; Lugnier C; Keravis T; Lopes MJ; Fantini FA; Schmitt M; Cortes SF; Lemos VS
Eur J Pharmacol; 2009 Oct; 620(1-3):78-83. PubMed ID: 19686719
[TBL] [Abstract][Full Text] [Related]
19. Intercellular and vascular cell adhesion molecule levels in endoscopic and open saphenous vein harvesting for coronary artery bypass surgery.
Alrawi SJ; Samee M; Raju R; Shirazian D; Acinapura AJ; Cunningham JN
Heart Surg Forum; 2000; 3(3):241-5. PubMed ID: 11074980
[TBL] [Abstract][Full Text] [Related]
20. [Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery].
Iwama Y; Mokuno H; Yokoi H; Daida H; Yamaguchi H; Hosoda Y
J Cardiol; 1998 Dec; 32(6):357-62. PubMed ID: 9914952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
